Cutaneous squamous cell carcinoma developing in lupus vulgaris exfoliativus persistent for 40 years

International Journal of Dermatology

Volumn 48, Issue 2, 2009, Pages 125-127

  Zawirska, Agnieszka ^a,b,c   Adamski, Zygmunt ^a,b,c   Stawicka, Ewa ^a,b,c   Schwartz, Robert A ^a,b,c  

^a University Hospital for Tumors   (Croatia)

^b Regional Hospital   (Poland)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMAZID; UNCLASSIFIED DRUG;

ACANTHOSIS; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DOSE RESPONSE; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; GRANULOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LUPUS VULGARIS; LYMPHOCYTIC INFILTRATION; MALE; MONOTHERAPY; PHOTOTOXICITY; PSORIASIS VULGARIS; SCAR FORMATION; SKIN BIOPSY; SKIN CARCINOMA; SKIN GRAFT; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; TUBERCULIN TEST;

AGED; ANTITUBERCULAR AGENTS; BIOPSY; CARCINOMA, SQUAMOUS CELL; HUMANS; LUPUS VULGARIS; MALE; SKIN NEOPLASMS; THIGH; TIME FACTORS;

EID: 59149096435     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.03850.x     Document Type: Article

References (20)

1. Wozniacka A, Schwartz RA, Sysa-Jedrzejowska A, et al. Lupus vulgaris: report of two cases. Int J Dermatol 2005; 44: 299-301.
2. Reich A, Kobierzycha M, Cislo C, et al. Psoriasiform lupus vulgaris. Scand J Inf Dis 2006; 38: 556-558.
3. Reichman LB. Timebomb: The Global Epidemic of Multi-Drug Resistant Tuberculosis. New York: McGraw-Hill, 2001.
4. Braun-Falco O, Plewig G, Wolff HH, et al. Dermatology, 2nd edn. Berlin: Springer, 2000: 202-218..
5. Gooptu C, Marks N, Thomas J, et al. Squamous cell carcinoma associated with lupus vulgaris. Clin Exp Dermatol 1998; 23: 99-102.
6. MacGregor R. Cutaneous tuberculosis. Clin Dermatol 1995; 13: 245-255.
7. Sowden J, Paramsouth Y, Smith AG. Malignant melanoma arising in the scar of lupus vulgaris and response to treatment with topical azelaic acid. Clin Exp Dermatol 1988; 13: 353-356.
8. Betti R, Tolomio E, Vergani R, et al. Plattenepithelkarzinom als Komplikation des Lupus vulgaris. Hautarzt, 2002; 52: 118-120.
9. Haim S, Friedman-Birnbaum R. Cutaneous tuberculosis and malignancy. Cutis, 1978; 21: 643-647.
10. Harrison PV, Marks JM. Lupus vulgaris and cutaneous lymphoma. Clin Exp Dermatol, 1980; 5: 73-77.
11. Kensler TW, Egner PA, Taffle BG, et al. Role of free radicals in tumour promotion and progression. In:
12. Slaga TJ, Klein-Szaub AJP, Boutwell RK, et al., eds. Skin Carcinogenesis: Mechanisms and Human Relevance. New York: Alan R. Liss, Inc., 1989: 233-248.
13. Ziegler A, Jonason A, Leffel DJ. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-776.
14. Barbagallo J, Tager P, Ingleton R, et al. Cutaneous tuberculosis: diagnosis and treatment. Am J Clin Dermatol 2002; 3: 319-328.
15. Iseman MD. Tuberculosis therapy: Past, present and future. Eur Respir J Suppl 2002; 36: 87-94.
16. Chinchila D, Martorano A, Rodriguez E, et al. Cutaneous tuberculosis: efficient therapeutic response in a case with multiple lesions. Cutis 1999; 64: 49-52.
17. Bilen N, Apaydin R, Harova G, et al. Lupus vulgaris on the buttock: report of two cases. J Eur Acad Dermatol Venereol 2000; 14: 65-66.
18. Helm F, Klein E, Flood TM. Lupus vulgaris. Skin (Los Angeles) 1964; 4: 262-266.
19. Masellis P, Gasparini G, Caputo R, Alessi E, et al. Tuberculosis verrucosa cutis which remained undiagnosed for forty-three years. Dermatology (Basel) 1995; 191: 145-148.
20. Fox H. Three unusual forms of cutaneous tuberculosis. J Cutan Dis Syph 1912; 30: 78-82.